Jennifer M. Taylor

发表

Narrow‐band imaging cystoscopy to evaluate bladder tumours – individual surgeon variability

G. Dalbagni, H. Herr, Machele Donat, 2009, BJU international.

Muscle-Invasive Urothelial Carcinoma: Conventional and Variant Subtypes

B. Bochner, M. Amin, D. Hansel, 2012 .

Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy: A Meta-analysis of Oncologic, Perioperative, and Complication-related outcomes.

B. Miles, C. Wallis, Jennifer M. Taylor, 2019, European urology oncology.

Suburethral sling at the time of radical prostatectomy in patients at high risk of postoperative incontinence

L. Pisters, O. Westney, E. McGuire, 2006, BJU international.

Clinical outcome of patients with T1 micropapillary urothelial carcinoma of the bladder.

V. Reuter, D. Sjoberg, H. Al-Ahmadie, 2013, The Journal of urology.

Pathological response to neoadjuvant chemotherapy for muscle‐invasive micropapillary bladder cancer

B. Bochner, G. Dalbagni, J. Meeks, 2013, BJU international.

Common approach to managing lower urinary tract symptoms and erectile dysfunction.

Jennifer M. Taylor, Run Wang, R. Desouza, 2008, Asian journal of andrology.

PD32-09 INNOVATIVE CHANGES IN A UROLOGY RESIDENCY PROGRAM CAN LOWER RATES OF RESIDENT BURNOUT

J. Anaissie, Jennifer M. Taylor, W. Mayer, 2020 .

Is a restaging TURBT necessary in high-risk NMIBC if the initial TURBT was performed with blue light?

Y. Lotan, S. Daneshmand, S. Porten, 2022, Urologic oncology.

Rare Metastatic Testicular Cancer in a Veteran

Jennifer M. Taylor, Umar Karaman, Faye B Serkin, 2017, Current Urology.

Comprehensive handbook for developing a bladder cancer cystectomy database.

Y. Lotan, S. Boorjian, N. Smith, 2013, Urologic oncology.

Approaches to Non-Muscle-Invasive Bladder Cancer

Jennifer M. Taylor, Hannah Slovacek, J. Zhuo, 2021, Current Oncology Reports.

Maximizing cure for muscle-invasive bladder cancer: integration of surgery and chemotherapy.

H. Herr, A. Feifer, Jennifer M. Taylor, 2011, European urology.

Penoscrotal extramammary Paget's disease: the University of Texas M. D. Anderson Cancer Center contemporary experience.

D. Ivan, V. Prieto, C. Pettaway, 2011, The Journal of urology.

Aminopeptidase activities as prospective urinary biomarkers for bladder cancer

I. Ostrovnaya, B. Bochner, H. Lilja, 2014, Proteomics. Clinical applications.

Combination of a Novel Gene Expression Signature with a Clinical Nomogram Improves the Prediction of Survival in High-Risk Bladder Cancer

Franziska Michor, Markus Riester, B. Bochner, 2012, Clinical Cancer Research.

Prognostic impact of muscular venous branch invasion in localized renal cell carcinoma cases.

W. Lowrance, P. Russo, V. Reuter, 2011, Journal of Urology.

Blue light cystoscopy for the diagnosis of bladder cancer: Results from the US prospective multicenter registry.

S. Daneshmand, T. Bivalacqua, J. Liao, 2018, Urologic oncology.

Imaging , Diagnosis , Prognosis Combination of a Novel Gene Expression Signature with a Clinical Nomogram Improves the Prediction of Survival in High-Risk Bladder Cancer

B. Bochner, M. Riester, J. Rosenberg, 2012 .

Bladder Cancer Nomogram Improves the Prediction of Survival in High-Risk Combination of a Novel Gene Expression Signature with a Clinical

B. Bochner, J. Rosenberg, F. Michor, 2012 .

Total Psoas Area Predicts Complications following Radical Cystectomy

J. Maranchie, B. Davies, J. Gingrich, 2015, Advances in urology.

Innovative Approaches to Battling Resident Burnout in a Urology Residency Program

J. Anaissie, Jennifer M. Taylor, W. Mayer, 2021, Urology practice.

Assessing Contemporary Trends in Female Speakership within Urologic Oncology.

Kirsten L. Greene, S. Psutka, E. Plimack, 2020, Urology.

Education Time Out and Debrief: Structured Implementation of Perioperative Resident Technical Education Discussion.

Jennifer M. Taylor, W. Mayer, S. Popat, 2020, Journal of the American College of Surgeons.

Urologic oncology workforce diversity: A first step in reducing cancer disparities.

T. Garg, Jennifer M. Taylor, A. Antar, 2019, Urologic oncology.

Efficacy and Safety of Blue Light Flexible Cystoscopy with Hexaminolevulinate in the Surveillance of Bladder Cancer: A Phase III, Comparative, Multicenter Study

Sanjay G. Patel, Y. Lotan, P. Pierorazio, 2017, The Journal of urology.

Utility of Blue Light Cystoscopy for Post-bacillus Calmette-Guérin Bladder Cancer Recurrence Detection: Implications for Clinical Trial Recruitment and Study Comparisons

M. Meng, Y. Lotan, S. Daneshmand, 2021, The Journal of urology.

Role of blue‐light cystoscopy in detecting invasive bladder tumours: data from a multi‐institutional registry

Y. Lotan, S. Daneshmand, S. Porten, 2021, BJU international.

Patient‐reported outcomes of blue‐light flexible cystoscopy with hexaminolevulinate in the surveillance of bladder cancer: results from a prospective multicentre study

Sanjay G. Patel, Y. Lotan, S. Daneshmand, 2018, BJU international.

Urology Match Outcomes during the Coronavirus Pandemic.

Jennifer M. Taylor, W. Mayer, Sagar R. Patel, 2021, The Journal of urology.

BLUE LIGHT FLEXIBLE CYSTOSCOPY (BLFC) WITH HEXAMINOLEVULINATE (HAL) AND WHITE LIGHT FLEXIBLE CYSTOSCOPY: A PROSPECTIVE, COMPARATIVE, WITHIN‐PATIENT CONTROLLED MULTI‐CENTER PHASE 3 STUDY IN THE DETECTION OF BLADDER CANCER DURING SURVEILLANCE: PPTLBA‐02

Sanjay G. Patel, Y. Lotan, S. Daneshmand, 2017 .

The case for salvage cystectomy after pelvic radiation.

S. Lerner, Jennifer M. Taylor, Carli E. Calderone, 2016, Minerva urologica e nefrologica = The Italian journal of urology and nephrology.

Pathological response to neoadjuvant chemotherapy for muscle‐invasive micropapillary bladder cancer

B. Bochner, G. Dalbagni, J. Meeks, 2013, BJU international.

Maximizing cure for muscle-invasive bladder cancer: integration of surgery and chemotherapy.

H. Herr, A. Feifer, Jennifer M. Taylor, 2011, European urology.